Teva CEO Talks Drug Pricing, Generics, Supply Shortages
Jan 13 2025
Length: 7 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Teva CEO Talks Drug Pricing, Generics, Supply Shortages

Listen for free

View show details

Summary
Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.

He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.
See omnystudio.com/listener for privacy information.

Show More Show Less

Only £0.99 a month for the first 3 months. Pay £0.99 for the first 3 months, and £7.99/month thereafter. Renews automatically. Terms apply. Start my membership

Show More Show Less

What listeners say about Teva CEO Talks Drug Pricing, Generics, Supply Shortages

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon